In addition, it was revealed that both PROCR+ cell percentage and PROCR expression level increased significantly in metastatic or recurrent NPC patients (Fig. 6b), supporting our findings that PROCR+ cells displayed stemness potential. This evidence concerns the gene PROCR and nasopharyngeal carcinoma.